
Employees: 1-10
Portfolio 20
Date | Name | Website | Total Raised | Location |
08.05.2022 | Nutcracker... | nutcrackerx.com | $227M | United Sta... |
04.01.2022 | Vandria | vandria.com | $51.3M | - |
05.05.2021 | Cytoki Pha... | cytokipharma.com | $45M | Denmark, G... |
- | Ionpath | ionpath.com | $18M | United Sta... |
- | SQZ Biotec... | sqzbiotech.com | $164M | United Sta... |
- | Amphivena | amphivena.com | $62M | - |
- | Orca Bio | orcabio.com | $300M | United Sta... |
- | Visby Medi... | visbymedical.com | $235M | United Sta... |
- | Serotiny | serotiny.bio | - | - |
- | Selecta Bi... | selectabio.com | $152.6M | United Sta... |
Show more
Persons 3
Date | First Name | Last Name | Title | Location | |||
- | Eric | Moessinger | Partner | - | %***m@nd.c... | - | |
- | Alison | Palmer | Vice Presi... | - | %***p@nd.c... | - | |
- | Gabriela | Ecco | Principal | - | %***e@nd.c... | - |
Mentions in press and media 15
Date | Title | Description |
08.05.2025 | HAYA Therapeutics: Pioneering the Future of RNA-Guided Therapies | In the world of biotechnology, innovation is the lifeblood. HAYA Therapeutics has just secured a hefty $65 million in Series A funding, a financial boost that could change the landscape of chronic and age-related disease treatment. This fun... |
08.05.2025 | HAYA Therapeutics banks $65 million Series A funding | HAYA Therapeutics is a biotechnology company pioneering precision RNA-guided regulatory genome targeting therapeutics that reprogram disease-driving cell states for rare, common, chronic and age-related diseases. The core of HAYA’s proprie... |
14.12.2023 | Vandria Announces $20.6M (CHF18M) Series A Financing Led by ND Capital to Drive CNS Clinical Program and Mitochondrial Therapeutics Platform | - |
25.09.2023 | Notify Therapeutics secures €5M to develop novel hormone-free fertility treatment for women | Read this article in: Copenhagen-based Notify Therapeutics, a “first-in-class” female fertility treatment, announced that it has secured €5M in a fresh round of funding. Notify Therapeutics, an initiative stemming from Professor Karin Lykke... |
21.09.2023 | CHF 45 million Investment takes H55 next level | H55 is at the forefront of revolutionizing the aviation industry with its cutting-edge electric propulsion technologies. The company's groundbreaking solutions are designed to enhance the sustainability, efficiency, and safety of the aerosp... |
05.05.2021 | Cytoki Pharma cierra una ronda de €38M liderada por Lundbeckfonden Emerge junto con Ysios Capital, Seventure Partners y +ND Capital | 05/05/2021 Nota de prensa YSIOS CAPITAL INVIERTE EN CYTOKI PHARMA. − La compañía biotecnológica Cytoki Pharma (Copenhague, Dinamarca) desarrolla nuevas proteínas basadas en interleuquina 22 (IL-22) para el tratamiento de lesiones epiteli... |
05.05.2021 | Cytoki Pharma secures $45M Series A round lead by Lundbeckfonden Emerge together with Ysios, Seventure Partners and +ND Capital | 05/05/2021 Press release CYTOKI PHARMA RAISES $45 MILLION SERIES A FINANCING. Proceeds to support the development of its lead program (lipidated IL-22) through clinical proof of concept in Inflammatory Bowel Disease and explore expansion... |
17.12.2020 | Energy storage investments 2020: VC and equity firms put more than $500 million in these 25 battery startups | With U.S. energy storage growing a lot this year, and poised to accelerate next, conditions are fertile for VC investors to look for startup innovation.Source: Wood Mackenzie Here’s a long and incomplete list of where venture firms are putt... |
04.12.2020 | Electric aircraft start-up H55 secures a CHF20 million investment | Silicon Valley-based firms, +ND Capital and Tippet Venture Partners led H55’s latest investment round. The funds will allow the company to expand its operations and engineering team to achieve the design and production certification from th... |
04.12.2020 | Electric aircraft start-up H55 secures a CHF20 million investment |
Show more